Expression of vascular endothelial growth factor (VEGF) and assessment of microvascular density with CD34 as prognostic markers for endometrial carcinoma

Romanian Journal of Morphology and Embryology

Volumn 51, Issue 4, 2010, Pages 677-682

  Guset G ^a   Costi, Simona ^b   Elena, Lazǎr ^b   Dema, Alis ^c   Cornianu, Mǎrioara ^c   Vernic, Corina ^c   Paiusan L ^d  

^a Department of Obstetrics and Gynecology   (Romania)

^b Clinical Emergency County Hospital Pius Brinzeu Timisoara   (Romania)

^c VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d VASILE GOLDIS WESTERN UNIVERSITY OF ARAD   (Romania)

Author keywords

Angiogenesis; CD34; Endometrial adenocarcinoma; VEGF

Indexed keywords

CD34 ANTIGEN; TUMOR MARKER; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ENDOMETRIUM TUMOR; FEMALE; HUMAN; IMMUNOLOGY; METABOLISM; MICROVASCULATURE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EQUUS ASINUS;

EID: 78649967689     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. FOLKMAN J, Tumor angiogenesis: therapeutic implications, N Engl J Med, 1971, 285(21):1182-1186.
2. RASILA KK, BURGER RA, SMITH H, LEE FC, VERSCHRAEGEN C, Angiogenesis in gynecological oncology - mechanism of tumor progression and therapeutic targets, Int J Gynecol Cancer, 2005, 15(5):710-726.
3. WEIDNER N, Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow, J Pathol, 1998, 184(2):119-122.
4. TORRY DS, HOLT VJ, KEENAN JA, HARRIS G, CAUDLE MR, TORRY RJ, Vascular endothelial growth factor in cycling human endometrium, Fertil Steril, 1996, 66(1):72-80.
5. MCLAREN J, Vascular endothelial growth factor and endometriotic angiogenesis, Hum Reprod Update, 2000, 6(1):45-55.
6. HEALY DL, ROGERS PAW, HII L, WINGFIELD M, Angiogenesis: a new theory for endometriosis, Hum Reprod Update, 1998,4(5):736-740.
7. WEIDNER N, Intratumor microvessel density as a prognostic factor in cancer, Am J Pathol, 1995, 147(1):9-19.
8. WEIDNER N, SEMPLE JP, WELCH WR, FOLKMAN J, Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma, N Engl J Med, 1991, 324(1):1-8.
9. KAKU T, KAMURA T, KINUKAWA N, KOBAYASHI H, SAKAI K, TSURUCHI N, SAITO T, KAWAUCHI S, TSUNEYOSHI M, NAKANO H, Angiogenesis in endometrial carcinoma, Cancer, 1997, 80(4):741-747.
10. KIRSCHNER CV, ALANIS-AMEZCUA JM, MARTIN VG, LUNA N, MORGAN E, YANG JJ, YORDAN EL, Angiogenesis factor in endometrial carcinoma: a new prognostic indicator?, Am J Obstet Gynecol, 1996, 174(6):1879-1882
11. discussion 1882-1884
12. SALVESEN HB, IVERSEN OE, AKSLEN LA, Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study, J Clin Oncol, 1999, 17(5):1382-1390.
13. ERDEM O, ERDEM M, DURSUN A, AKYOL G, ERDEM A, Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: comparison with traditional clinicopathologic variables, Int J Gynecol Pathol, 2003, 22(3):254-260.
14. ERDEM O, ERDEM M, ERDEM A, MEMIS L, AKYOL G, Expression of vascular endothelial growth factor and assessment of microvascular density with CD 34 and endoglin in proliferative endometrium, endometrial hyperplasia, and endometrial carcinoma, Int J Gynecol Cancer, 2007, 17(6):1327-1332.
15. GIATROMANOLAKI A, SIVRIDIS E, BREKKEN R, THORPE PE, ANASTASIADIS P, GATTER KC, HARRIS AL, KOUKOURAKIS MI; TUMOUR AND ANGIOGENESIS RESEARCH GROUP, The angiogenic vascular endothelial growth factor/flk-1(KDR) receptor pathway in patients with endometrial carcinoma: prognostic and therapeutic implications, Cancer, 2001, 92(10):2569-2577.
16. SIVRIDIS E, Angiogenesis and endometrial cancer, Anticancer Res, 2001, 21(6B):4383-4388.
17. DVORAK HF, BROWN LF, DETMAR M, DVORAK AM, Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis, Am J Pathol, 1995, 146(5):1029-1039.
18. TORRY DS, TORRY RJ, Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta, Am J Reprod Immunol, 1997, 37(1):21-29.
19. ZHANG L, SCOTT PA, TURLEY H, LEEK R, LEWIS CE, GATTER KC, HARRIS AL, MACKENZIE IZ, REES MC, BICKNELL R, Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium, J Pathol, 1998, 185(4):402-408.
20. GARGETT CE, LEDERMAN FL, LAU TM, TAYLOR NH, ROGERS PA, Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium, Hum Reprod, 1999, 14(8):2080-2088.
21. ARCHER DF, NAVARRO FJ, LESLIE S, MIRKIN S, Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17beta-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells, Fertil Steril, 2004, 81(1):165-170.
22. MUELLER MD, VIGNE JL, PRITTS EA, CHAO V, DREHER E, TAYLOR RN, Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells, Fertil Steril, 2003, 79(2):386-392.
23. HUANG JC, LIU DY, DAWOOD MY, The expression of vascular endothelial growth factor isoforms in cultured human endometrial stromal cells and its regulation by 17betaoestradiol, Mol Hum Reprod, 1998, 4(6):603-607.
24. SHIFREN JL, TSENG JF, ZALOUDEK CJ, RYAN IP, MENG YG, FERRARA N, JAFFE RB, TAYLOR RN, Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis, J Clin Endocrinol Metab, 1996, 81(8):3112-3118.
25. FINE BA, VALENTE PT, FEINSTEIN GI, DEY T, VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma, Gynecol Oncol, 2000, 76(1):33-39.
26. YOKOYAMA Y, SATO S, FUTAGAMI M, FUKUSHI Y, SAKAMOTO T, UMEMOTO M, SAITO Y, Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma, Gynecol Oncol, 2000, 77(3):413-418.
27. HOLLAND CM, DAY K, EVANS A, SMITH SK, Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer, Br J Cancer, 2003, 89(5):891-898.
28. SAITO M, SATO Y, WATANABE J, KURAMOTO H, KABA S, FUKUDA T, Angiogenic factors in normal endometrium and endometrial adenocarcinoma, Pathol Int, 2007, 57(3):140-147.
29. CHARNOCK-JONES DS, SHARKEY AM, RAJPUT-WILLIAMS J, BURCH D, SCHOFIELD JP, FOUNTAIN SA, BOOCOCK CA, SMITH SK, Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines, Biol Reprod, 1993, 48(5):1120-1128.
30. SEKI N, KODAMA J, HONGO A, MIYAGI Y, YOSHINOUCHI M, KUDO T, Vascular endothelial growth factor and plateletderived endothelial cell growth factor expression are implicated in the angiogenesis of endometrial cancer, Eur J Cancer, 2000, 36(1):68-73.
31. FUJISAWA T, WATANABE J, AKABOSHI M, OHNO E, KURAMOTO H, Immunohistochemical study on VEGF expression in endometrial carcinoma - comparison with p53 expression, angiogenesis, and tumor histologic grade, J Cancer Res Clin Oncol, 2001, 127(11):668-674.